Similar Articles
421 RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
422 Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
423 Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
424 Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
425 Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
426 Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
427 Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
428 Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
429 Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection
430 Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA